Pharmacological characterization of GPR55, a putative cannabinoid receptor
- 1 June 2010
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 126 (3) , 301-313
- https://doi.org/10.1016/j.pharmthera.2010.02.004
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivoProceedings of the National Academy of Sciences, 2009
- Receptors for acylethanolamides—GPR55 and GPR119Prostaglandins & Other Lipid Mediators, 2009
- Paracrine Transactivation of the CB1 Cannabinoid Receptor by AT1 Angiotensin and Other Gq/11 Protein-coupled ReceptorsPublished by Elsevier ,2009
- The therapeutic potential of novel cannabinoid receptorsPharmacology & Therapeutics, 2009
- GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M currentProceedings of the National Academy of Sciences, 2008
- Cannabinoid receptors and the regulation of bone massBritish Journal of Pharmacology, 2008
- CB2receptors in the brain: role in central immune functionBritish Journal of Pharmacology, 2008
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effectsBritish Journal of Pharmacology, 2007
- Mitogenic signaling pathways induced by G protein‐coupled receptorsJournal of Cellular Physiology, 2007